106 related articles for article (PubMed ID: 8784240)
1. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.
Yatsugi S; Takahashi M; Kawasaki-Yatsugi S; Koshiya K; Sakamoto S; Uematsu D; Shimizu-Sasamata M
J Cereb Blood Flow Metab; 1996 Sep; 16(5):959-66. PubMed ID: 8784240
[TBL] [Abstract][Full Text] [Related]
2. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
3. YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Yatsugi SI; Shimizu-Sasamata M; Koshiya K; Shishikura JI; Sakamoto S; Yamaguchi T
J Pharmacol Exp Ther; 1998 Feb; 284(2):467-73. PubMed ID: 9454786
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
Bullock R; Graham DI; Swanson S; McCulloch J
J Cereb Blood Flow Metab; 1994 May; 14(3):466-71. PubMed ID: 8163588
[TBL] [Abstract][Full Text] [Related]
5. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
Umemura K; Shimakura A; Nakashima M
Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
[TBL] [Abstract][Full Text] [Related]
7. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T
J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454
[TBL] [Abstract][Full Text] [Related]
8. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
[TBL] [Abstract][Full Text] [Related]
9. A potent AMPA/kainate receptor antagonist, YM90K, attenuates the loss of N-acetylaspartate in the hippocampal CA1 area after transient unilateral forebrain ischemia in gerbils.
Nakano M; Ueda H; Li JY; Matsumoto M; Yanagihara T
Life Sci; 2001 Sep; 69(17):1983-90. PubMed ID: 11589513
[TBL] [Abstract][Full Text] [Related]
10. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
12. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
[TBL] [Abstract][Full Text] [Related]
14. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
15. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
[TBL] [Abstract][Full Text] [Related]
16. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.
Ozyurt E; Graham DI; Woodruff GN; McCulloch J
J Cereb Blood Flow Metab; 1988 Feb; 8(1):138-43. PubMed ID: 2892846
[TBL] [Abstract][Full Text] [Related]
18. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
19. Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.
Mackay KB; Kusumoto K; Graham DI; McCulloch J
Brain Res; 1993 Aug; 618(2):213-9. PubMed ID: 8397047
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats.
Akiho H; Iwai A; Tsukamoto S; Koshiya K; Yamaguchi T
Neuropharmacology; 1998; 37(2):159-68. PubMed ID: 9680240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
